TP53 and neoplasm: Downregulation of Myod, Myh1, and p53 mRNA levels was observed in TNBC and ER+/PR+ tumor-bearing mice, compared with ER+/PR− PDXs which showed no significant difference, relative to control (Fig. 2D–F).